The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

by Murphy Daniel R, Smolen Lee J, Klein Timothy M, Klein Robert W
Published 2012-10-01

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia

by Smolen Lee, Rousculp Matthew D, Klein Robert, Meadows Eric S, Ohsfeldt Robert L, Johnston Joseph A
Published 2007-04-01

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

by Smolen Lee J, Klein Robert W, Ascher-Svanum Haya, Furiak Nicolas M, Lawson Anthony H, Conley Robert R, Culler Steven D
Published 2009-04-01